Wholesale of pharmaceutical and medical goods
KARO PHARMA AS
Revenue 2024
NOK 714.3m
Operating profit
NOK 179.5m
Equity
NOK 202.8m
Incorporated
1940
Employees
22
Share capital
NOK 6.8m
Key figures · 2024
Current ratio
1.55
Equity ratio
40.4%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 25.1% | |
| Net margin (%%) | 20.5% | |
| Return on assets (%%) | 35.7% | |
| Likviditet | ||
| Current ratio | 1.55 | |
| Working capital | 166.2m | |
| Soliditet | ||
| Equity ratio (%%) | 40.4% | |
| Debt-to-equity ratio | 1.48 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.